title: Advancements in ocular drug delivery.
abstract: This review covers both noninvasive and invasive ophthalmic drug delivery systems that can have application to therapy of veterinary ophthalmic diseases. Noninvasive approaches include gel technologies, permeation enhancement via pro-drug development, solubilization agents and nanoparticle technologies, iontophoresis, microneedles, drug-eluting contact lenses and eye misters, and microdroplets. More invasive systems include both eroding implants and noneroding technologies that encompass diffusion based systems, active pumps, intraocular lenses, suprachoroidal drug delivery, and episcleral reservoirs. In addition to addressing the physiologic challenges of achieving the necessary duration of delivery, tissue targeting and patient compliance, the commercial development factors of biocompatibility, sterilization, manufacturability and long-term stability will be discussed.
authors.affiliation: Alcon Research Ltd., Fort Worth, TX, USA.
authors.forename: Alan L
authors.initials: AL
authors.lastname: Weiner
authors.forename: Brian C
authors.initials: BC
authors.lastname: Gilger
mesh_terms: D000287:Administration, Topical; D000818:Animals; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems / Q000662:veterinary*; D005128:Eye Diseases / Q000188:drug therapy / Q000662:veterinary*; D019736:Prostheses and Implants / Q000662:veterinary
chemical_list: D003692:Delayed-Action Preparations